Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Other solid neoplasm 3Thoracic 1Lymphoid 1Head & Neck 1Gynecologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 168Rituximab 161Specimen Handling 115Biopsy 91Magnetic Resonance Spectroscopy 89Vincristine 84Doxorubicin 78Prednisone 75fludarabine 71venetoclax 69obinutuzumab 62ibrutinib 55Lenalidomide 55Dexamethasone 55Cytarabine 48Methotrexate 47acalabrutinib 43Etoposide 41CT-P10 41blinatumomab 40fludarabine phosphate 35Gemcitabine 33Bendamustine Hydrochloride 33zanubrutinib 31pembrolizumab 30glofitamab 30Calcium Dobesilate 30prednylidene 29deltacortene 28Nivolumab 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Behavior Therapy × Lymphoid × 90 days × Clear all
NCT01503632 2026-04-08

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

Children's Oncology Group

Phase 3 Completed
570 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡